Accretion Pharmaceuticals Ltd

NEW
NSE:ACCPL (India)  
₹ 163.45 -0.65 (-0.4%) Jul 21
18.10
P/B:
3.33
Market Cap:
₹ 1.82B ($ 18.82M)
Enterprise V:
₹ 1.90B ($ 19.68M)
Volume:
2.40K
Avg Vol (2M):
23.47K
Trade In:

Accretion Pharmaceuticals Ltd (NSE:ACCPL) Dividend

Accretion Pharmaceuticals Ltd (NSE:ACCPL) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of 1.2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: NSE:ACCPL Dividend

Does Accretion Pharmaceuticals Ltd (NSE:ACCPL) pay a dividend?

Accretion Pharmaceuticals Ltd (NSE:ACCPL) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Accretion Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Accretion Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of 1.2% over the past 3 years.

What are dividend-paying alternatives to Accretion Pharmaceuticals Ltd?

For dividend-paying alternatives in Accretion Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.